| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anticoagulating patients with high-risk acquired thrombophilias
|
Skeith, Leslie
|
|
|
132 |
21 |
p. 2219-2229
|
artikel
|
| 2 |
A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia
|
Chen, Lisa S.
|
|
|
132 |
21 |
p. 2249-2259
|
artikel
|
| 3 |
A small change makes a big difference in Hodgkin lymphoma
|
Hutchings, Martin
|
|
|
132 |
21 |
p. 2214-2215
|
artikel
|
| 4 |
Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions
|
Vazquez, Sara R.
|
|
|
132 |
21 |
p. 2230-2239
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
132 |
21 |
p. i
|
artikel
|
| 6 |
Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes
|
Nagata, Yasunobu
|
|
|
132 |
21 |
p. 2309-2313
|
artikel
|
| 7 |
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
|
Wagener, Rabea
|
|
|
132 |
21 |
p. 2280-2285
|
artikel
|
| 8 |
Improving CLL Vγ9Vδ2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib
|
de Weerdt, Iris
|
|
|
132 |
21 |
p. 2260-2272
|
artikel
|
| 9 |
Is less equal with ibrutinib dose?
|
Rogers, Kerry A.
|
|
|
132 |
21 |
p. 2211-2212
|
artikel
|
| 10 |
Microgranular variant of acute promyelocytic leukemia with cytoplasmic projections resembling micromegakaryocytes
|
Jiang, Wei
|
|
|
132 |
21 |
p. 2314
|
artikel
|
| 11 |
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma
|
Kobe, Carsten
|
|
|
132 |
21 |
p. 2273-2279
|
artikel
|
| 12 |
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma
|
Tun, Han W.
|
|
|
132 |
21 |
p. 2240-2248
|
artikel
|
| 13 |
Postthrombotic syndrome: simple prevention
|
Solymoss, Susan
|
|
|
132 |
21 |
p. 2216-2217
|
artikel
|
| 14 |
Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis
|
Amin, Elham E.
|
|
|
132 |
21 |
p. 2298-2304
|
artikel
|
| 15 |
SKI controls MDS-associated chronic TGF-β signaling, aberrant splicing, and stem cell fitness
|
Muench, David E.
|
|
|
132 |
21 |
p. e24-e34
|
artikel
|
| 16 |
γδ T cells for immunotherapy
|
Long, Meixiao
|
|
|
132 |
21 |
p. 2212-2213
|
artikel
|
| 17 |
Tfr2 suppression benefits β-thalassemic erythropoiesis
|
Ginzburg, Yelena Z.
|
|
|
132 |
21 |
p. 2215-2216
|
artikel
|
| 18 |
Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model
|
Artuso, Irene
|
|
|
132 |
21 |
p. 2286-2297
|
artikel
|
| 19 |
Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma
|
Lemonnier, François
|
|
|
132 |
21 |
p. 2305-2309
|
artikel
|
Tijdschrift beschrijving